Evidence map›Paper›PMID 40940976›Full record

ArticleCancers2025

Anticancer Effects of Ascorbic Acid: Not All Sides Fit All.

Uche O Arunsi, Jeremiah O Olugbami, Adegboyega K Oyelere

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Two-color spheroid model for determining the OJournal of biological engineering · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Uche O ArunsiSchool of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive, Atlanta, GA 30332, USA.ORCID 0000-0002-5315-2695
Jeremiah O OlugbamiSchool of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive, Atlanta, GA 30332, USA.
Adegboyega K OyelereSchool of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive, Atlanta, GA 30332, USA.ORCID 0000-0002-2248-9551

Funding

Reposition and Optimization of Deferiprone for Breast Cancer TherapyR01CA252720 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI OYELERE, ADEGBOYEGA · 2021 to 2025
$2.4M
NCI NIH HHS R01 CA252720USA National Institute of Health R01CA252720
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosisascorbic acidcancer cell proliferationcell imagingcell viability assessmentlipid peroxidationMTS assayMTT assayPI/Triton X-100 assayROS

Identifiers

PMID40940976
PMCPMC12427553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.